Reduced pleural drainage, length of stay, and readmissions using a modified Fontan management protocol  Nancy A. Pike, PhD, Carol A. Okuhara, MN, Joy.

Slides:



Advertisements
Similar presentations
Lost in translation The Journal of Thoracic and Cardiovascular Surgery
Advertisements

Manuel J. Antunes, MD, PhD, DSc 
Stephen R. Broderick, MD, MPHS 
One in every 14 patients with early-stage lung cancer is not being treated!  Benny Weksler, MD, MBA  The Journal of Thoracic and Cardiovascular Surgery 
Superior postoperative pain relief with thoracic epidural analgesia versus intravenous patient-controlled analgesia after minimally invasive pectus excavatum.
The days of future past  Neel K. Ranganath, MD, Aubrey C. Galloway, MD 
Ground glass opacity of the lung: The veil that needs lifting
Murray H. Kwon, MD  The Journal of Thoracic and Cardiovascular Surgery 
Intrinsic cardiac stem cells are essential for regeneration
Centers for Disease Control “increased-risk” organ donor: Not so risky?  Francis D. Pagani, MD, PhD  The Journal of Thoracic and Cardiovascular Surgery 
Abracadabra I, II…HeartMate 3?
Exposed thoracic aortic endovascular stent graft
Victor van Berkel, MD, PhD 
William M. DeCampli, MD, PhD 
Skinning the cat: Another wrinkle for T-tube insertion
Multilevel data analysis: What? Why? How?
How should we treat air leaks?
Go on-pump or off-pump in diabetic patients?
New treatment approaches create new disease processes: A short guide on how to reduce unexpected events to a minimum  Martin Czerny, MD, MBA  The Journal.
The lord of the rings  Antonio Miceli, MD, PhD 
Franco Stella, MD, PhD, Francesco Petrella, MD 
The variability of the mitral valve anatomy and terminology
Support Your Specialty
Innovation and science: The future of valve design
A fairy tale future for Fontans: Fact or fable?
The assessment of cost effectiveness and the effectiveness of cost assessment in cardiothoracic surgery  Vinay Badhwar, MD  The Journal of Thoracic and.
It's not “just a shunt” but sometimes it should be…
Fixing the supply problem
Military surgeons just want to have fun
A first start for lung transplantation?
Confusion still exists regarding postoperative delirium and its etiology after esophagectomy  Robert B. Cameron, MD  The Journal of Thoracic and Cardiovascular.
Sutureless pneumostasis using bioabsorbable mesh and glue during major lung resection for cancer: Who are the best candidates?  Kazuhiro Ueda, MD, Toshiki.
Stephen R. Broderick, MD, MPHS 
Administration of recombinant activated factor VII in the intensive care unit after complex cardiovascular surgery: Clinical and economic outcomes  Walter.
Joseph A. Dearani, MD, Michael J. Ackerman, MD, PhD 
Choice of second pericardial drainage tube for posterior placement
Resection of primary lung cancer with incidental pleural seeding: Seeds of change or reap what you sow?  Jules Lin, MD  The Journal of Thoracic and Cardiovascular.
A case of chest wall angiosarcoma associated with breast implants
Jeevanantham Rajeswaran, PhD, Eugene H. Blackstone, MD 
Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD 
Niv Ad, MD, Lawrence M. Wei, MD 
Instrumental variable methods in clinical research
Attachment disorder in thoracoabdominal surgery
Video-assisted resection for lung cancer results in fewer complications  Lunxu Liu, PhD, MD, FRCS  The Journal of Thoracic and Cardiovascular Surgery 
Passing the torch The Journal of Thoracic and Cardiovascular Surgery
Robert James Cerfolio, MD, FACS, FCCP, Ayesha S. Bryant, MSPH, MD 
Patients with unbalanced atrioventricular canal defects can undergo the Fontan operation with good outcomes  Sitaram M. Emani, MD  The Journal of Thoracic.
The harder one looks, the more one finds
The origins of open heart surgery at the University of Minnesota 1951 to 1956  Richard A. DeWall, MD  The Journal of Thoracic and Cardiovascular Surgery 
The Journal of Thoracic and Cardiovascular Surgery
Discussion The Journal of Thoracic and Cardiovascular Surgery
The future of cardiac surgery training: A survival guide
Commentary: “Isn't cardiac surgery a team sport?”
Minor postoperative morbidity should not be neglected
Ventricular assistant in restrictive cardiomyopathy: Making the right connection  Robert D.B. Jaquiss, MD  The Journal of Thoracic and Cardiovascular Surgery 
Relevance of the Surgical Care Improvement Project on glycemic control in patients undergoing cardiac surgery who receive continuous insulin infusions 
Hope should not spring eternal
The continuing challenge of congenital heart disease in China
Postoperative medication management after surgical ablation: Clarifying the role of amiodarone therapy  Hersh Maniar, MD, Eric Novak, MS  The Journal.
Ralph E. Delius, MD  The Journal of Thoracic and Cardiovascular Surgery 
Should it stay or should it go?
“The more things change…”: The challenges ahead
Commentary: Judgment day: Should you add atrial fibrillation ablation?
Why arch curvature affects arch resistance
Preoperative PFTs: The answer is blowing in the wind
Did you like Terminator 3 better than Terminator 2
A good chimney requires a good sweep
How do we follow up our patients
Journal changes and initiatives
Deciding how much to pay for effective care
Presentation transcript:

Reduced pleural drainage, length of stay, and readmissions using a modified Fontan management protocol  Nancy A. Pike, PhD, Carol A. Okuhara, MN, Joy Toyama, MS, Barbara P. Gross, MSN, Winfield J. Wells, MD, Vaughn A. Starnes, MD  The Journal of Thoracic and Cardiovascular Surgery  Volume 150, Issue 3, Pages 481-487 (September 2015) DOI: 10.1016/j.jtcvs.2015.06.042 Copyright © 2015 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Duration of pleural drainage between groups as determined by the number of postoperative days (PODs) before chest tubes (CT) were removed. The bold horizontal black line indicates the median number of PODs before CTs were removed. Lighter horizontal lines framing the border of the box indicates the 25th and 75th percentiles for each patient group. The open circles indicate the outliers in each patient group and the whiskers depicted by the outer horizontal lines connected to the vertical dashed lines indicate the minimum and maximum values, excluding the outliers. The Journal of Thoracic and Cardiovascular Surgery 2015 150, 481-487DOI: (10.1016/j.jtcvs.2015.06.042) Copyright © 2015 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Comparison between groups in hospital length of stay measured in postoperative days. The bold horizontal black line indicates the median length of stay after Fontan. Lighter horizontal lines framing the border of the box indicates the 25th and 75th percentiles for each patient group. The open circles indicate the outliers in each patient group and the whiskers depicted by the outer horizontal lines connected to the vertical dashed lines indicate the minimum and maximum values, excluding the outliers. The Journal of Thoracic and Cardiovascular Surgery 2015 150, 481-487DOI: (10.1016/j.jtcvs.2015.06.042) Copyright © 2015 The American Association for Thoracic Surgery Terms and Conditions

Comparison between groups in hospital length of stay measured in postoperative days. The Journal of Thoracic and Cardiovascular Surgery 2015 150, 481-487DOI: (10.1016/j.jtcvs.2015.06.042) Copyright © 2015 The American Association for Thoracic Surgery Terms and Conditions